The dynamic nature of Bruch's membrane

https://doi.org/10.1016/j.preteyeres.2009.08.003Get rights and content

Abstract

Bruch's membrane (BM) is a unique pentalaminar structure, which is strategically located between the retinal pigment epithelium (RPE) and the fenestrated choroidal capillaries of the eye. BM is an elastin- and collagen-rich extracellular matrix that acts as a molecular sieve. BM partly regulates the reciprocal exchange of biomolecules, nutrients, oxygen, fluids and metabolic waste products between the retina and the general circulation. Accumulating evidence suggests that the molecular, structural and functional properties of BM are dependent on age, genetic constitution, environmental factors, retinal location and disease state. As a result, part of the properties of BM are unique to each human individual at a given age, and therefore uniquely affect the development of normal vision and ocular disease.

The changes occurring in BM with age include increased calcification of elastic fibres, increased cross-linkage of collagen fibres and increased turnover of glycosaminoglycans. In addition, advanced glycation end products (AGEs) and fat accumulate in BM.

These age-related changes may not only influence the normal age-related health of photoreceptor cells, but also the onset and progression of diseases like retinitis pigmentosa (RP) and age-related macular degeneration (AMD). Undoubtedly, BM is the site of drusen development. Confluent drusen and uncontrolled activation of the complement cascade are most likely the first signs of AMD. Furthermore, the nature of adhesive interactions between the RPE and BM are instrumental in the development of retinal detachments and proliferative retinal disease. Finally, BM is passively or actively involved in a range of other retinal disorders such as Pseudoxanthoma elasticum (PXE), Sorsby's Fundus Dystrophy and Malattia Leventinese.

Here, we review the dynamic nature of Bruch's membrane, from molecule to man, during development, aging and disease. We propose a simple and straightforward nomenclature for BM deposits. Finally, we attempt to correlate recently published mRNA expression profiles of the RPE and choroid with molecular, structural and functional properties of BM. Our review may shed light on the complex involvement of BM in retinal pathology, notably age-related macular degeneration.

Introduction

In the past, many investigators considered Bruch's membrane (BM) a relatively boring and simple sheet of extracellular matrix, merely occupying space between the retinal pigment epithelium (RPE) and the choroid. Recently, however, interest in BM has increased exponentially; and understandably so, given its strategic location between the retina and the general circulation, and its crucial role in retinal function, aging and ocular disease. The pentalaminar BM structure forms a single functional unit with the RPE and choriocapillaris. It is involved in the essential exchange of numerous biomolecules, oxygen, nutrients and waste products in between these tissues. Given its unique location and structure, BM plays a crucial role in cell–cell communication, cellular differentiation, proliferation or migration, tissue remodelling and in shaping pathologic processes (Takei and Ozanics, 1975, Olson, 1979, Campochiaro et al., 1986, Guymer et al., 1999). The nature of BM is highly dynamic, and depends on genetic factors, environmental burden, the topographic position in the retina, age and disease (Hogan and Alvarado, 1967, Crabb et al., 2002, Klein et al., 2004, Curcio et al., 2005, van Soest et al., 2007, Bhutto et al., 2008, Booij et al., 2009). It has also become clear that BM is the focal point of local and systemic risk factors for initial stages of the most frequent untreatable blinding disorder known to man: age-related macular degeneration (AMD). In addition, BM is primarily or secondarily involved in a number of additional genetically determined ophthalmic disorders such proliferative vitreoretinopathy (PVR) (Stone et al., 1992, Pastor et al., 2002), pseudoxanthoma elasticum (PXE) (Aessopos et al., 1989, van Soest et al., 1997), Marfan syndrome (McKusick et al., 1972, Appel et al., 1979, Beighton et al., 1988), Sorsby's fundus dystrophy (Sorsby and Mason, 1949, Capon et al., 1989, Ayyagari et al., 2000) and others.

Here, we review the existing knowledge on BM, with a focus on its normal structure and function (Section 2) and the role of BM in normal aging and early AMD pathology (Section 3). Finally, we provide an outlook on possible AMD disease prevention or treatment (Section 4).

Section snippets

Development of BM

The retina is a derivative of the neuroectoderm of the diencephalon. Around the 4th week of gestation, a secondary eye bubble, surrounded by ectoderm and mesenchyme, develops, which forms the future optic cup. Upon invagination of the optic cup in the sixth week of development, the future RPE and the undifferentiated neural retina can be distinguished. In the next stage, neural crest-derived mesenchyme, which will form the future choroid, starts to condensate around the optic cup. At the same

Normal aging of BM and AMD pathology

The distinction between normal aging and pathology in, for example, AMD, is not clear cut. Interestingly, aging itself is the strongest risk factor for developing AMD. However, features of aging and disease may overlap, may be different for different cell types involved, and may even raise an almost philosophical discussion. For example, some investigators view aging itself as a pathology, that can ultimately be cured, while others do not.

Here, we consider “normal aging” those changes that

Summarizing the events leading up to early AMD

The molecular pathology of AMD has recently been reviewed extensively elsewhere (Ding et al., 2009). In summary, Ding et al. (2009) reviewed clinical, epidemiological, and genetic aspects of AMD, as well as the use of mouse models for potential AMD therapy. In contrast, we here reviewed the central role of BM in normal retinal aging, in drusen formation and in the early stages of AMD.

Obviously, the normal function and pathology of BM can only be understood in the context of the molecular and

Acknowledgements

The authors thank the ‘Algemene Nederlandse Vereniging ter Voorkoming van Blindheid’ (ANVVB), the Macula Foundation of the Netherlands, the ‘Landelijke Stichting voor Blinden en Slechtzienden’, the ‘Rotterdamse Blinden Belangen’, the ‘Blindenpenning’, the ‘Gelderse Blinden Vereniging’, and ‘Stichting Uitzicht’ for their financial contributions.

References (165)

  • C.A. Curcio et al.

    Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy

    Exp. Eye Res.

    (2005)
  • L.V. Del Priore et al.

    Maculoplasty for age-related macular degeneration: reengineering Bruch's membrane and the human macula

    Prog. Retin. Eye Res.

    (2006)
  • X. Ding et al.

    Molecular pathology of age-related macular degeneration

    Prog. Retin. Eye Res.

    (2009)
  • I.M. Fang et al.

    Overexpression of integrin alpha6 and beta4 enhances adhesion and proliferation of human retinal pigment epithelial cells on layers of porcine Bruch's membrane

    Exp. Eye Res.

    (2009)
  • J. Gong et al.

    Effects of extracellular matrix and neighboring cells on induction of human embryonic stem cells into retinal or retinal pigment epithelial progenitors

    Exp. Eye Res.

    (2008)
  • A. Gugliucci et al.

    Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance

    Clin. Chim. Acta

    (2007)
  • V.K. Gullapalli et al.

    Impaired RPE survival on aged submacular human Bruch's membrane

    Exp. Eye Res.

    (2005)
  • R. Guymer et al.

    Changes in Bruch's membrane and related structures with age

    Prog. Retin. Eye Res.

    (1999)
  • G.S. Hageman et al.

    An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration

    Prog. Retin. Eye Res.

    (2001)
  • X. He et al.

    Iron homeostasis and toxicity in retinal degeneration

    Prog. Retin. Eye Res.

    (2007)
  • X. Hu et al.

    Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update

    Surv. Ophthalmol.

    (2003)
  • J.D. Huang et al.

    Age-related changes in human macular Bruch's membrane as seen by quick-freeze/deep-etch

    Exp. Eye Res.

    (2007)
  • M. Inatani et al.

    Proteoglycans in retina

    Prog. Retin. Eye Res.

    (2002)
  • G.R. Jackson et al.

    Photoreceptor degeneration and dysfunction in aging and age-related maculopathy

    Ageing Res. Rev.

    (2002)
  • S.G. Jarrett et al.

    Mitochondrial DNA damage and its potential role in retinal degeneration

    Prog. Retin. Eye Res.

    (2008)
  • R. Klein et al.

    The epidemiology of age-related macular degeneration

    Am. J. Ophthalmol.

    (2004)
  • R. Klein et al.

    Inflammation, complement factor h, and age-related macular degeneration: the multi-ethnic study of Atherosclerosis

    Ophthalmology

    (2008)
  • T. Kurz et al.

    Autophagy, ageing and apoptosis: the role of oxidative stress and lysosomal iron

    Arch. Biochem. Biophys.

    (2007)
  • R.B. Maccioni et al.

    The molecular bases of Alzheimer's disease and other neurodegenerative disorders

    Arch. Med. Res.

    (2001)
  • The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS report No. 7

    J. Nutr.

    (2002)
  • S. Aisenbrey et al.

    Retinal pigment epithelial cells synthesize laminins, including laminin 5, and adhere to them through alpha3- and alpha6-containing integrins

    Invest. Ophthalmol. Vis. Sci.

    (2006)
  • T.A. Albini et al.

    Microglial stability and repopulation in the retina

    Br. J. Ophthalmol.

    (2005)
  • H. Altunay

    Fine structure of the retinal pigment epithelium, Bruch's membrane and choriocapillaris in the camel

    Anat. Histol. Embryol.

    (2007)
  • AREDS annual report

    A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

    Arch. Ophthalmol.

    (2001)
  • R. Ayyagari et al.

    Autosomal dominant hemorrhagic macular dystrophy not associated with the TIMP3 gene

    Arch. Ophthalmol.

    (2000)
  • P. Beighton et al.

    International nosology of heritable disorders of connective tissue, Berlin, 1986

    Am. J. Med. Genet.

    (1988)
  • A.A. Bergen et al.

    Mutations in ABCC6 cause pseudoxanthoma elasticum

    Nat. Genet.

    (2000)
  • I.A. Bhutto et al.

    Reduction of endogenous angiogenesis inhibitors in Bruch's membrane of the submacular region in eyes with age-related macular degeneration

    Arch. Ophthalmol.

    (2008)
  • D. Bok

    The retinal pigment epithelium: a versatile partner in vision

    J. Cell Sci. Suppl.

    (1993)
  • J.C. Booij et al.

    Functional annotation of the human retinal pigment epithelium transcriptome

    BMC Genomics

    (2009)
  • Booij, Judith C., ten Brink, Jacoline B., Swagemakers, Sigrid M.A., Verkerk, Annemieke J.M.H., Essing, Anke H.W., van...
  • C. Bowes Rickman et al.

    Defining the human macula transcriptome and candidate retinal disease genes using EyeSAGE

    Invest. Ophthalmol. Vis. Sci.

    (2006)
  • C.R. Braekevelt

    Fine structure of the choriocapillaris, Bruch's membrane and retinal epithelium in the sheep

    Anat. Embryol. (Berl)

    (1983)
  • N.M. Bressler et al.

    Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration

    Retina

    (1994)
  • G.J. Brewer

    Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer's disease

    Exp. Biol. Med. (Maywood)

    (2007)
  • P.A. Campochiaro et al.

    The extracellular matrix of human retinal pigment epithelial cells in vivo and its synthesis in vitro

    Invest. Ophthalmol. Vis. Sci.

    (1986)
  • C. Chen et al.

    Scotopic sensitivity of central retina in early age-related macular degeneration

    Yan Ke Xue Bao

    (2003)
  • C. Chen et al.

    The local cone and rod system function in early age-related macular degeneration

    Doc. Ophthalmol.

    (2004)
  • J.Y. Chuo et al.

    Use of lipid-lowering agents for the prevention of age-related macular degeneration: a meta-analysis of observational studies

    Ophthal. Epidemiol.

    (2007)
  • J.W. Crabb et al.

    Drusen proteome analysis: an approach to the etiology of age-related macular degeneration

    Proc. Natl. Acad. Sci. USA

    (2002)
  • Cited by (435)

    • Modeling complex age-related eye disease

      2024, Progress in Retinal and Eye Research
    View all citing articles on Scopus
    View full text